Klinik für Frauenheilkunde und Geburtshilfe - Lehrstuhl der Universität Regensburg

Publikationen

Originalarbeiten

Inwald EC, Döllinger M, Schuster M, Eysholdt U, Bohr C (2011) Multiparametric analysis of vocal fold vibrations in healthy and disordered voices in high-speed imaging. J Voice. 2011 Sep;25(5):576-90.

Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat. 2013 Jun;139(2):539-52.

Inwald EC, Ortmann O, Zeman F, Koller M, Hofstädter F, Gerstenhauer M, Klinkhammer-Schalke M (2014) Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients – Results from a large population-based cohort of a cancer registry. Biomed Res Int. 2014;2014:137304.

Inwald EC, Klinkhammer-Schalke M, Koller M, Ortmann O (2014) Quality Assurance for Patients with Breast Cancer – the Impact of Clinical Cancer Registries. Geburtshilfe Frauenheilkd 2014; 74(9): 868-874.

Seitz S, Buchholz S, Schally AV, Weber F, Klinkhammer-Schalke M, Inwald EC, Perez R, Rick FG, Szalontay L, Hohla F, Segerer S, Kwok CW, Ortmann O, Engel JB (2014) Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125. BMC Cancer. 2014 Nov 19;14(1):847.

Lindberg P, Koller M, Steinger B, Lorenz W, Wyatt JC, Inwald EC, Klinkhammer-Schalke M (2015) Breast cancer survivors' recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial. BMC Cancer. 2015 Jul 29;15(1):554. doi: 10.1186/s12885-015-1573-6.

Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofstädter F, Lindberg P, Gerstenhauer M, Schüler S, Treeck O, Ortmann O (2015) Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry. J Cancer Res Clin Oncol. 2015 Aug 8.

Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofstädter F, Gerstenhauer M, Brockhoff G, Ortmann O (2015) 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival. Breast Cancer Res Treat. 2015 Oct;153(3):647-58. doi: 10.1007/s10549-015-3572-3. Epub 2015 Sep 14

Skrzypczak M, Merx I, Schüler-Toprak S, Weber F, Inwald EC, Ortmann O, Treeck O (2015) Molecular profiling of estrogen receptor α and progesterone receptor transcript variants in endometrial cancer.Steroids. 2015 Sep 30. pii: S0039-128X(15)00243-3. doi: 10.1016/j.steroids.2015.09.004.

Nemec W, Inwald EC, Buchholz S, Klinkhammer Schalke M, Gerken M, Ortmann O (2016)

Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma. Arch Gynecol Obstet. 2016 Oct;294(4):825-31. doi: 10.1007/s00404-016-4086-x.

Schüler-Toprak S, Häring J, Inwald EC, Moehle C, Ortmann O, Treeck O (2016) Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro. BMC Cancer. 2016 Dec 21;16(1):951. doi: 10.1186/s12885-016-2973-y.

Inwald EC, Ortmann O, Koller M, Zeman F, Hofstädter F, Evert M, Brockhoff G, Klinkhammer-Schalke M (2017) Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat. 2017 May;163(1):119-130. doi: 10.1007/s10549-017-4151-6. Epub 2017 Feb 15.

Holzschuh MA, Czyz Z, Hauke S, Inwald EC, Polzer B, Brockhoff G (2017) HER2 FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes - reclassifying cases in the equivocal category. Histopathology. 2017 May 14. doi: 10.1111/his.13253. [Epub ahead of print]

Oberguggenberger AS, Nagele E, Inwald EC, Tomaszewski K, Lanceley A, Nordin A, Creutzberg CL, Kuljanic K, Kardamakis D, Schmalz C, Arraras J, Costantini A, Almont T, Wei-Chu C, Dehandschutter S, Winters Z, Greimel E; EORTC Quality of Life Group (2018) Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22. Cancer Med. 2018 Mar;7(3):635-645. doi: 10.1002/cam4.1338. Epub 2018 Feb 13.

Übersichtsarbeiten

Inwald EC (2013) Zur Konsistenz der Ki-67-Bestimmung in realen Versorgungsstrukturen. Patho.Punkt Nov 4.2013, Mitgliedermagazin Bundesverband Deutscher Pathologen e.V.

M. Klinkhammer-Schalke, O. Ortmann, EC Inwald, H. Barlag, S. Wesselmann (2014) Klinische Krebsregister – regionale Umsetzung, Aufgaben und Perspektiven, Frauenheilkunde up 2 date 2014; 8(5): 295-298 DOI: 10.1055/s-0033-1357997.

M. Klinkhammer-Schalke, P. Lindberg, M. Koller, B. Steinger, O. Ortmann, A. Hofstädter, A. Scharl, EC Inwald, W. Lorenz (2014) Patientenwohl. Lebensqualität bei Brustkrebs-Patientinnen – Implementierung und Umsetzung in die Routineversorgung, Geburtshilfe Frauenheilkd 2014; 74(6): 531-534 DOI: 10.1055/s-0034-1368626.

Inwald EC, Ortmann O. (2014) Prävention des Mammakarzinoms mit SERM und Aromatasehemmern, Gynäkologische Endokrinologie 2014 · 12:253–257 DOI 10.1007/s10304-014-0630-6.

EC Inwald, C. Lattrich, O. Ortmann (2015) Risikokommunikation vor Einsatz medikamentöser Therapien - Beispiel Hormontherapie in der Peri- und Postmenopause, Der Gynäkologe August 2015, Volume 48, Issue 8, pp 581-585 DOI 10.1007/s00129-015-3729-5

Kontaktieren Sie uns

Priv.-Doz. Dr. med.
Elisabeth C. Inwald
AG Versorgungsforschung     
 
Mail einwald@caritasstjosef.de

 

Kontakt Anfahrt Seite drucken© 2002-2017 Caritas-Krankenhaus St. Josef | Impressum | Datenschutz | Sitemap | Design & Programmmierung